BusinessuniQure Delivers Oral Presentation on Broad Set of Preclinical Data on AMT-130 in Huntington’s Disease at the 2018 American Academy of Neurology Annual MeetingBy Nasdaq OMXApr 25, 2018, 8:15 PM UTC
BusinessRaptor’s PROCYSBI® New Drug Submission Accepted by Health Canada with Priority ReviewBy Nasdaq OMXMar 21, 2016, 8:05 PM UTC
BusinessRaptor Pharmaceutical to Participate in the Cowen and Company 36th Annual Health Care ConferenceBy Nasdaq OMXMar 1, 2016, 12:30 PM UTC
BusinessRaptor Pharmaceutical Corp. Reports Fourth Quarter and Full Year 2015 Financial Results and Provides 2016 Corporate UpdateBy Nasdaq OMXFeb 25, 2016, 9:05 PM UTC
